CAPR vs VMEO
Comparison between Capricor Therapeutics Inc (CAPR, Company) and Vimeo Inc (VMEO, Company).
CAPR is from the Healthcare sector, while VMEO is from the Technology sector.
5-Year PerformanceCAPR has outperformed VMEO, delivering a return of +36.3% compared to -32.3%
CAPR vs VMEO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CAPR vs VMEO - Historical Returns
Returns include dividend reinvestment.
CAPR vs VMEO - Annual Returns (2007 - 2026)
Returns include dividend reinvestment.
| Year | CAPR | VMEO |
|---|---|---|
| 2026 | -21.41% | N/A |
| 2025 | +92.91% | +21.14% |
| 2024 | +169.53% | +67.98% |
| 2023 | +27.01% | +12.64% |
| 2022 | +21.38% | -80.83% |
| 2021 | -21.66% | -60.43% |
| 2020 | +178.86% | N/A |
| 2019 | -74.14% | N/A |
| 2018 | -73.89% | N/A |
| 2017 | -38.04% | N/A |
| 2016 | -9.52% | N/A |
| 2015 | -18.04% | N/A |
| 2014 | +10.29% | N/A |
| 2013 | +62.50% | N/A |
| 2012 | -90.91% | N/A |
| 2011 | -5.17% | N/A |
| 2010 | -48.76% | N/A |
| 2009 | +51.25% | N/A |
| 2008 | -84.55% | N/A |
| 2007 | +511.11% | N/A |
CAPR vs VMEO Drawdown Comparison
The maximum drawdown for CAPR was -99.97%, occurring on Mar 10, 2020. This drawdown has not yet recovered.
The maximum drawdown for VMEO was -94.14%, occurring on Oct 27, 2023. This drawdown has not yet recovered.
The current CAPR drawdown is -99.32%. The current VMEO drawdown is -84.81%.
| Rank | CAPR | VMEO |
|---|---|---|
| #1 | -99.97% Oct 24, 2007 - Mar 10, 2020 | -94.14% Jul 7, 2021 - Oct 27, 2023 |
| #2 | -56.27% Feb 14, 2007 - Sep 18, 2007 | -11.87% May 25, 2021 - Jun 8, 2021 |
| #3 | -2.33% Sep 25, 2007 - Oct 5, 2007 | -7.42% Jun 8, 2021 - Jun 25, 2021 |
| #4 | -2.22% Oct 5, 2007 - Oct 24, 2007 | -2.67% Jun 25, 2021 - Jun 29, 2021 |
| #5 | N/A | -2.20% Jul 1, 2021 - Jul 6, 2021 |
| #6 | N/A | -0.99% Jun 29, 2021 - Jul 1, 2021 |
Correlation
Correlation between CAPR and VMEO is -0.20 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks